# Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)

> **NCT00431548** · NA · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 30 (—)

## Conditions studied

- HIV Infections
- Retina
- Ocular Physiology

## Interventions

- **DRUG:** 100% O2

## Key facts

- **NCT ID:** NCT00431548
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (—)
- **Last updated:** 2007-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00431548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00431548, "Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT00431548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*